Keyword: thyroid


Amgen-Horizon Deal under Intense Scrutiny

08.02.2023 -

Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...


UK Watchdog Finds Concordia Guilty of Market Abuse

30.11.2017 - In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...


Genzyme to Acquire AstraZeneca Rare Disease Therapy

29.07.2015 - French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...